Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Executive Officer

CHIEF SCIENTIFIC OFFICER

GENERAL COUNSEL

Chief Scientific Officer

General Counsel

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including large molecules, such as peptides, proteins, and antibodies. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. The company was incorporated in 2012 and is headquartered in San Jose, California.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-12-06	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-12-04	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-11-29	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-11-24	Premium	bought	Premium	Premium	Premium	-
2023-11-24	Premium	sold	Premium	Premium	Premium	-
2023-11-17	Premium	bought	Premium	Premium	Premium	-
2023-11-16	Premium	bought	Premium	Premium	Premium	-
2023-11-07	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-05-12	Premium	bought	Premium	Premium	Premium	-
2023-05-11	Premium	bought	Premium	Premium	Premium	-
2023-05-08	Premium	bought	Premium	Premium	Premium	-
2023-05-03	Premium	bought	Premium	Premium	Premium	-
2023-04-28	Premium	bought	Premium	Premium	Premium	-
2023-04-25	Premium	bought	Premium	Premium	Premium	-
2023-04-24	Premium	bought	Premium	Premium	Premium	-
2023-04-21	Premium	bought	Premium	Premium	Premium	-
2023-04-20	Premium	bought	Premium	Premium	Premium	-
2023-04-18	Premium	bought	Premium	Premium	Premium	-
2023-04-14	Premium	bought	Premium	Premium	Premium	-
2023-04-13	Premium	bought	Premium	Premium	Premium	-
2023-04-12	Premium	bought	Premium	Premium	Premium	-
2023-04-11	Premium	bought	Premium	Premium	Premium	-
2023-04-10	Premium	bought	Premium	Premium	Premium	-
2023-04-06	Premium	bought	Premium	Premium	Premium	-
2023-04-05	Premium	bought	Premium	Premium	Premium	-

RANI - Rani Therapeutics Holdings, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for RANI